CaridianBCT, Inc. Release: National Institutes of Health (NIH) Clinical Center Confirms Quality of Clinical-Grade Cells Produced by the Quantum(R) Cell Expansion System

LAKEWOOD, Colo.--(BUSINESS WIRE)--CaridianBCT, the leading global provider of technology, products and services in the blood banking, transfusion medicine and cell therapy industries, announced today that the National Institutes of Health (NIH) Clinical Center has verified the consistent cell yields and cell quality produced by a prototype of the Quantum Cell Expansion System, commending the system’s ability to reproducibly expand clinical doses of bone marrow stromal cells (BMSC), also known as mesenchymal stem cells. With these findings, the agency recently purchased the commercially available system for use in future clinical applications.